ClinicalTrials.gov
public full text
Public Domain
Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD
SHIELD HD is an international, multisite, prospective, longitudinal cohort natural history study to assess the natural history of HD and its biomarkers that are associated with modulation of the number of cytosine-adenine-guanine (CAG) repeats in the mutant Huntingtin (HTT) gene. Approximately 60 patients will be enrolled into the study and followed for up to 24 months at clinical sites in North America and Europe. The results of this study will inform assessments for a future interventional treatment trial.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- N- Homocysteinylated Huntingtin in Huntington's Disease#882171
- iPSC Neurodegenerative Disease Initiative isogenic CAG repeat iPSC line for Huntingtons disease#422357
- Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers#1364436
- REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)#833884
- An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196#896852
Record · ID 1382595
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive